• SENSEX
    NIFTY 50
Healthcare

DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine

Updated : July 30, 2020 07:26 AM IST

The panel also recommended that the proposed clinical trial sites be distributed across India, the source said.
Oxford University recently had announced satisfactory progress with the vaccine.
DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine

You May Also Like

Live TV
Advertisement